首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide autonomic activity and cardiovascular risk
【2h】

Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide autonomic activity and cardiovascular risk

机译:发现控制一氧化氮自主神经活动和心血管疾病风险的GTP环水解酶1(GCH1)常见人类遗传变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

GTP cyclohydrolase 1 (GCH1) is rate limiting in the provision of the cofactor tetrahydrobiopterin for biosynthesis of catecholamines and NO. We asked whether common genetic variation at GCH1 alters transmitter synthesis and predisposes to disease. Here we undertook a systematic search for polymorphisms in GCH1, then tested variants’ contributions to NO and catecholamine release as well as autonomic function in twin pairs. Renal NO and neopterin excretions were significantly heritable, as were baroreceptor coupling (heart rate response to BP fluctuation) and pulse interval (1/heart rate). Common GCH1 variant C+243T in the 3′-untranslated region (3′-UTRs) predicted NO excretion, as well as autonomic traits: baroreceptor coupling, maximum pulse interval, and pulse interval variability, though not catecholamine secretion. In individuals with the most extreme BP values in the population, C+243T affected both diastolic and systolic BP, principally in females. In functional studies, C+243T decreased reporter expression in transfected 3′-UTRs plasmids. We conclude that human NO secretion traits are heritable, displaying joint genetic determination with autonomic activity by functional polymorphism at GCH1. Our results document novel pathophysiological links between a key biosynthetic locus and NO metabolism and suggest new strategies for approaching the mechanism, diagnosis, and treatment of risk predictors for cardiovascular diseases such as hypertension.
机译:在提供辅助因子四氢生物蝶呤用于生物合成儿茶酚胺和NO时,GTP环水解酶1(GCH1)受到速率限制。我们询问了GCH1的常见遗传变异是否会改变递质的合成并易患疾病。在这里,我们对GCH1中的多态性进行了系统的搜索,然后测试了变体对NO和儿茶酚胺释放以及成对双胞胎的自主功能的贡献。肾NO和新蝶呤的排泄物显着遗传,压力感受器耦合(心率对BP波动的反应)和脉搏间隔(1 /心率)也很明显。 3'-非翻译区(3'-UTR)中常见的GCH1变体C + 243T预测NO排泄以及自主性:压力感受器耦合,最大脉冲间隔和脉冲间隔可变性,尽管儿茶酚胺分泌不大。在人群中具有最高BP值的个体中,C + 243T影响舒张压和收缩压,主要在女性中。在功能研究中,C + 243T降低了转染的3'-UTRs质粒中报告基因的表达。我们得出的结论是,人的NO分泌性状是可遗传的,通过GCH1的功能多态性显示具有自主活动的联合遗传测定。我们的研究结果记录了关键的生物合成基因座与NO代谢之间的新型病理生理联系,并提出了新的策略来探讨心血管疾病(例如高血压)的危险因素的机制,诊断和治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号